Gabelli Funds LLC Abbott Laboratories Transaction History

Gabelli Funds LLC

$12.8 Billion
Q3 2024

A detailed history of Gabelli Funds LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Gabelli Funds LLC holds 64,600 shares of ABT stock, worth $7.41 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

64,600

Previous 67,800 4.72%

Holding current value

$7.41 Million

Previous $7.05 Million 4.54%

% of portfolio

0.06%

Previous 0.06%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $320,224 - $378,016	-3,200 Reduced 4.72%	64,600 $7.37 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $45,095 - $55,200	-500 Reduced 0.73%	67,800 $7.46 Million
Q2 2023 Aug 10, 2023	SELL	$100.78 - $112.29 $201,560 - $224,580	-2,000 Reduced 2.84%	68,300 $7.45 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $465,794 - $546,448	4,900 Added 7.49%	70,300 $7.72 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $115,530 - $141,460	-1,000 Reduced 1.51%	65,400 $9.2 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $244,986 - $271,026	-2,100 Reduced 3.07%	66,400 $7.84 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $1.06 Million - $1.25 Million	-10,000 Reduced 12.74%	68,500 $7.94 Million
Q4 2020 Feb 05, 2021	SELL	$105.0 - $114.42 $210,000 - $228,840	-2,000 Reduced 2.48%	78,500 $8.6 Million
Q3 2020 Nov 06, 2020	SELL	$91.64 - $111.29 $2.93 Million - $3.56 Million	-32,000 Reduced 28.44%	80,500 $8.76 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $880,554 - $1.13 Million	-11,500 Reduced 9.27%	112,500 $10.3 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $2.14 Million - $3.12 Million	-34,000 Reduced 21.52%	124,000 $9.79 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $14.3 Million - $15.9 Million	-182,000 Reduced 53.53%	158,000 $13.7 Million
Q3 2019 Nov 01, 2019	BUY	$81.84 - $88.74 $9.08 Million - $9.85 Million	111,000 Added 48.47%	340,000 $28.4 Million
Q2 2019 Aug 02, 2019	SELL	$72.88 - $85.0 $18.8 Million - $21.9 Million	-257,900 Reduced 52.97%	229,000 $19.3 Million
Q1 2019 May 02, 2019	SELL	$66.22 - $80.06 $2.38 Million - $2.87 Million	-35,900 Reduced 6.87%	486,900 $38.9 Million
Q4 2018 Jan 30, 2019	BUY	$65.56 - $74.27 $6.52 Million - $7.38 Million	99,400 Added 23.48%	522,800 $37.8 Million
Q3 2018 Nov 02, 2018	BUY	$60.81 - $73.36 $1.64 Million - $1.98 Million	27,000 Added 6.81%	423,400 $31.1 Million
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $2.3 Million - $2.54 Million	-40,000 Reduced 9.17%	396,400 $24.2 Million
Q1 2018 May 09, 2018	BUY	$56.27 - $63.62 $562,700 - $636,200	10,000 Added 2.35%	436,400 $26.1 Million
Q4 2017 Feb 02, 2018	BUY	$53.68 - $57.47 $805,200 - $862,050	15,000 Added 3.65%	426,400 $24.3 Million
Q3 2017 Nov 01, 2017	BUY	$48.06 - $53.64 $19.8 Million - $22.1 Million	411,400	411,400 $22 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Account

Gabelli Funds LLC Abbott Laboratories Transaction History